Trademark: 97608226
Word
LIFE. SCIENCE. ACORDA THERAPEUTICS
Status Date
Tuesday, January 9, 2024
Filing Date
Tuesday, September 27, 2022
Published for Opposition
Tuesday, May 23, 2023
41 Entertainment and educational services, namely, providing live and online seminars, conferences and workshops concerning issues related to diseases, disorders and conditions and distributing informational course materials in connection therewith
35 Promoting public awareness of the need for education, research, treatment and a cure for diseases, disorders and conditions
44 Providing health information; providing information and online information relating to diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations for the prevention and treatment of diseases, disorders and conditions
The mark consists of the mark "LIFE. SCIENCE." on a first line, the mark "ACORDA" with a lightning bolt diagonally through the "O" on a second line with an underscore thereunder and the term "THERAPEUTICS" spaced directly under the underscore on a third line.
Color is not claimed as a feature of the mark.
"SCIENCE" AND "THERAPEUTICS"
Jan 11, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 9, 2024
Sou Extension 1 Granted
Jan 9, 2024
Sou Extension 1 Filed
Jan 9, 2024
Sou Teas Extension Received
Jul 18, 2023
Noa E-Mailed - Sou Required From Applicant
May 23, 2023
Official Gazette Publication Confirmation E-Mailed
May 23, 2023
Published For Opposition
May 3, 2023
Notification Of Notice Of Publication E-Mailed
Apr 20, 2023
Approved For Pub - Principal Register
Apr 19, 2023
Teas/Email Correspondence Entered
Apr 18, 2023
Correspondence Received In Law Office
Apr 18, 2023
Teas Response To Office Action Received
Jan 25, 2023
Notification Of Non-Final Action E-Mailed
Jan 25, 2023
Non-Final Action E-Mailed
Jan 25, 2023
Non-Final Action Written
Dec 12, 2022
Assigned To Examiner
Oct 14, 2022
Notice Of Design Search Code E-Mailed
Oct 13, 2022
New Application Office Supplied Data Entered
Sep 30, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
